Health Intelligence

Risk Medical Solutions has been working in collaboration with the UK based software company Health Intelligence since 2010 in bringing new and innovative diabetic retinopathy screening solutions to the market.

The objective of the collaboration is to improve diabetic retinopathy screening management by utilizing patient’s risk estimates for developing diabetic retinopathy.

One of the main goals is to adjust estimates of the DR Risk algorithm to the Scottish diabetic retinopathy-grading scheme. A validation study of nearly 10 thousand diabetic patients is now being performed. First results are promising and suggest that the algorithm can be successfully adjusted to predict earlier stages of diabetic retinopathy.

Other objectives include constructing risk profiles of the cohort as well as identifying high-risk patients. This can, amongst other, be used to target non-compliant patients who are at high risk of developing sight-threatening retinopathy.

This collaboration gives only a few examples of how risk profiling can be used to improve both retinopathy screening management as well as increase patient’s safety.